SHELX

SHELX performs structure solution and refinement for small-molecule crystallography and experimental phasing of macromolecules using direct methods, density modification, and autotracing.


Key Features:

  • Structure solution (SHELXS, SHELXD): SHELXS and SHELXD implement direct methods and iterative dual-space algorithms to locate atomic positions and anomalous scatterers.
  • Refinement (SHELXL): SHELXL performs small-molecule refinement and supports refinement against neutron diffraction data, treatment of hydrogen atoms, determination of absolute structure, input of partial structure factors, and handling of twinned and disordered structures.
  • Macromolecular phasing (SHELXC/D/E): SHELXC, SHELXD, and SHELXE provide experimental phasing workflows for SAD, MAD, SIR, SIRAS, and RIP and integrate into automated structure-solution pipelines.
  • Iterative density modification and autotracing (SHELXE): SHELXE applies iterative density modification with autotracing to identify alpha-helices and common tripeptides and to assess solution status.
  • CIF integration: SHELXL workflows are integrated with the CIF format so a single CIF can contain reflection data and SHELXL instructions as a complete structure archive.
  • High-throughput phasing: The suite implements iterative dual-space direct methods that combine phase refinement in reciprocal space with peak picking in real space to rapidly locate anomalous scatterers for high-throughput pipelines.
  • Patterson-based seeding and resolution truncation: SHELXD supports Patterson-based seeding to enhance anomalous scatterer location, with performance often improved by truncating data at ~3.0-3.5 Å.
  • Performance and parallelism: Implementations emphasize speed and robustness suitable for integration into automated and high-throughput phasing workflows.

Scientific Applications:

  • Small-molecule crystallography: Structure solution and refinement including neutron-data refinement, hydrogen-atom treatment, absolute-structure determination, and handling of twinned or disordered crystals.
  • Macromolecular experimental phasing: Initial phasing of proteins and complexes using SAD, MAD, SIR, SIRAS, and RIP approaches and locating anomalous scatterers.
  • Automated structure-solution pipelines: Integration of SHELXC/D/E and SHELXE autotracing into automated workflows for rapid structure determination.
  • Data archiving and validation: Use of CIF files to archive reflection data together with SHELXL instructions for validation and deposition.

Methodology:

Computational methods explicitly include direct methods (SHELXS/SHELXD), experimental phasing protocols (SAD, MAD, SIR, SIRAS, RIP), iterative dual-space direct methods combining phase refinement in reciprocal space with peak picking in real space, Patterson-based seeding with optional data truncation (~3.0-3.5 Å), iterative density modification and autotracing (SHELXE), and the use of CIF files containing reflection data and SHELXL instructions.

Topics

Collections

Details

Cost:
Free of charge
Tool Type:
workflow
Operating Systems:
Linux, Windows, Mac
Added:
2/16/2015
Last Updated:
11/24/2024

Operations

Publications

Schneider TR, Sheldrick GM. Substructure solution with<i>SHELXD</i>. Acta Crystallographica Section D Biological Crystallography. 2002;58(10):1772-1779. doi:10.1107/s0907444902011678. PMID:12351820.

Sheldrick GM. Phase annealing in SHELX-90: direct methods for larger structures. Acta Crystallographica Section A Foundations of Crystallography. 1990;46(6):467-473. doi:10.1107/s0108767390000277.

Sheldrick GM. A short history of<i>SHELX</i>. Acta Crystallographica Section A Foundations of Crystallography. 2007;64(1):112-122. doi:10.1107/s0108767307043930. PMID:18156677.

Sheldrick GM. Crystal structure refinement with<i>SHELXL</i>. Acta Crystallographica Section C Structural Chemistry. 2015;71(1):3-8. doi:10.1107/s2053229614024218. PMID:25567568. PMCID:PMC4294323.

Sheldrick GM. Experimental phasing with <i>SHELXC</i>/<i>D</i>/<i>E</i>: combining chain tracing with density modification. Acta Crystallographica Section D Biological Crystallography. 2010;66(4):479-485. doi:10.1107/s0907444909038360. PMID:20383001. PMCID:PMC2852312.

Documentation